US approves Pfizer COVID booster for the elderly and high-risk
Al Jazeera
The US has argued it can both provide booster shots at home while distributing doses abroad amid global disparity.
The US has authorised the administration of boosters of the Pfizer-BioNTech COVID-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.
The announcement means a significant part of the US population – amounting to tens of millions of Americans – are now eligible for a third shot six months after their second.
“Today’s action demonstrates that science and the currently available data continue to guide the FDA’s decision-making for COVID-19 vaccines during this pandemic,” said Janet Woodcock, acting head of the Food and Drug Administration, in a statement.
More Related News